File:The impact of lymphangiogenesis in transplant arteriosclerosis.png
From Wikimedia Commons, the free media repository
Jump to navigation
Jump to search
![File:The impact of lymphangiogenesis in transplant arteriosclerosis.png](https://upload.wikimedia.org/wikipedia/commons/thumb/d/dc/The_impact_of_lymphangiogenesis_in_transplant_arteriosclerosis.png/800px-The_impact_of_lymphangiogenesis_in_transplant_arteriosclerosis.png?20240426170203)
Size of this preview: 800 × 395 pixels. Other resolutions: 320 × 158 pixels | 640 × 316 pixels | 1,024 × 506 pixels | 1,280 × 632 pixels | 3,271 × 1,615 pixels.
Original file (3,271 × 1,615 pixels, file size: 1.25 MB, MIME type: image/png)
File information
Structured data
Captions
Captions
Add a one-line explanation of what this file represents
Summary
[edit]DescriptionThe impact of lymphangiogenesis in transplant arteriosclerosis.png | Figure 5. The impact of lymphangiogenesis in transplant arteriosclerosis. After vascular transplantation, the immediate recognition of donor artery components progressively induces immunological rejection response. After injecting a highly selective inhibitor for VEGFR3, the inhibition of lymphangiogenesis effectively suppresses the cellular adaptive immunity, and further ameliorates neointimal hyperplasia, adventitial fibrosis, and teritary lymphoid organs’ (TLOs) formation in vascular allografts. Resultantly, an immunosuppressive circle was reasonably achieved by the negative lymphangiogenesis manipulating. LEC: lymphatic endothelial cell. |
Date | |
Source | https://www.mdpi.com/cells/cells-11-04056/article_deploy/html/images/cells-11-04056-g003.png https://doi.org/10.3390/cells11244056 The Impact of Stem/Progenitor Cells on Lymphangiogenesis in Vascular Disease. Cells 2022, 11, 4056. |
Author | Mou, R.; Chen, K.; Zhu, P.; Xu, Q.; Ma, L. |
![]() |
This file, which was originally posted to an external website, has not yet been reviewed by an administrator or reviewer to confirm that the above license is valid. See Category:License review needed for further instructions.
|
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Licensing
[edit]![w:en:Creative Commons](https://upload.wikimedia.org/wikipedia/commons/thumb/7/79/CC_some_rights_reserved.svg/90px-CC_some_rights_reserved.svg.png)
![attribution](https://upload.wikimedia.org/wikipedia/commons/thumb/1/11/Cc-by_new_white.svg/24px-Cc-by_new_white.svg.png)
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
[[Category:Lymphangiogenesis]
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 17:02, 26 April 2024 | ![]() | 3,271 × 1,615 (1.25 MB) | Rasbak (talk | contribs) | {{Information |description=Figure 5. The impact of lymphangiogenesis in transplant arteriosclerosis. After vascular transplantation, the immediate recognition of donor artery components progressively induces immunological rejection response. After injecting a highly selective inhibitor for VEGFR3, the inhibition of lymphangiogenesis effectively suppresses the cellular adaptive immunity, and further ameliorates neointimal hyperplasia, adventitial fibrosis, and teritary lymphoid organs’ (TLOs)... |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
Hidden categories: